NCT05036967

Brief Summary

Researchers want to learn more about the treatments doctors choose to treat heart failure. Heart failure means the heart isn't pumping as well as it should be. Heart failure can lead to other serious medical conditions, and it can lead to hospitalization or death. There are different types of treatments available for people who have heart failure, and these work in different ways. In this study, the researchers will collect information about Colombian patients who have heart failure. The main purpose of this study is to identify patterns in the treatments that doctors first prescribe to heart failure patients in Columbia. To do this, the researchers will review information from the patients' medical records and from a drug-dispensing database. The study will include adult patients who have been diagnosed with heart failure in Columbia from June 1st, 2019 to May 31st, 2020. There will be no required visits, treatments, or procedures in this study. The researchers will collect information about the treatments the patients have been prescribed by their own doctors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2021

Completed
13 days until next milestone

Study Start

First participant enrolled

August 1, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 8, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2022

Completed
Last Updated

December 15, 2022

Status Verified

December 1, 2022

Enrollment Period

1.3 years

First QC Date

July 19, 2021

Last Update Submit

December 14, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Treatment initiation patterns

    Treatment initiation patterns of patients with Heart Failure (HF) in an outpatient setting from Colombia.

    Database analysis: HF patients from June 1st, 2019 to May 31st, 2020

Secondary Outcomes (16)

  • Clinical characteristics at baseline - Symptoms and signs: Dyspnea

    Database analysis: HF patients from June 1st, 2019 to May 31st, 2020

  • Clinical characteristics at baseline - Symptoms and signs: Fatigue

    Database analysis: HF patients from June 1st, 2019 to May 31st, 2020

  • Clinical characteristics at baseline - Symptoms and signs: Lower limb edema

    Database analysis: HF patients from June 1st, 2019 to May 31st, 2020

  • Clinical characteristics at baseline - Laboratory data: Hemoglobin and hematocrit level

    Database analysis: HF patients from June 1st, 2019 to May 31st, 2020

  • Clinical characteristics at baseline - Laboratory data: Left ventricular ejection fraction (LVEF)

    Database analysis: HF patients from June 1st, 2019 to May 31st, 2020

  • +11 more secondary outcomes

Study Arms (1)

Heart Failure (HF) patients

Patients diagnosed with incident HF, in an outpatient setting in Colombia during the time period of 01 JUN 2019 to 31 MAY 2020

Drug: HF medication

Interventions

Treatment initiation patterns of patients with Heart Failure (HF) in an outpatient setting from Colombia.

Heart Failure (HF) patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with incident HF, in an outpatient setting in Colombia during the time period of 01 JUN 2019 to 31 MAY 2020. The universe of the study corresponds to all individuals who are identified in the database as having HF diagnosed by ICD-10 code in the prescription; the target population corresponds to subjects who were diagnosed and prescribed with a HF treatment at the selected health insurance company and whose prescriptions were filled in Audifarma.

You may qualify if:

  • Adult patients (older than 18 years) with a diagnosis of HF according to ICD-10 with a dispensing of some medicine and it is registered in the database of Audifarma S.A. during the observation period will be included

You may not qualify if:

  • Patients with Acute HF without prior diagnosis of HF

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Many Locations

Multiple Locations, Colombia

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2021

First Posted

September 8, 2021

Study Start

August 1, 2021

Primary Completion

November 16, 2022

Study Completion

November 16, 2022

Last Updated

December 15, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Availability of this study's data will later be determined according to Bayer's commitment to the EFPIA/PhRMA "Principles for responsible clinical trial data sharing". This pertains to scope, timepoint and process of data access. As such, Bayer commits to sharing upon request from qualified researchers patient-level clinical trial data, study-level clinical trial data, and protocols from clinical trials in patients for medicines and indications approved in the US and EU as necessary for conducting legitimate research. This applies to data on new medicines and indications that have been approved by the EU and US regulatory agencies on or after January 01, 2014. Interested researchers can use www.clinicalstudydatarequest.com to request access to anonymized patient-level data and supporting documents from clinical studies to conduct research. Information on the Bayer criteria for listing studies and other relevant information is provided in the Study sponsors section of the portal.

Locations